{"id":"CHEMBL103735","canonicalSmiles":"CCCC1(CCC)CCC2(CCN(CCCN(CC)CC)C2)CC1","inchiKey":"SERHTTSLBVGRBY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATIPRIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Atiprimod","SKF-106615"],"crossReferences":{"Wikipedia":["Atiprimod"],"drugbank":["DB05513"]},"childChemblIds":["CHEMBL3989809","CHEMBL3215883"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL104","canonicalSmiles":"Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1","inchiKey":"VNFPBHJOKIVQEB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOTRIMAZOLE","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Abtrim","Actavall","Candiden","Canesten","Canesten af","Canesten crm combi","Canesten internal","Canesten vc","Clotrimazole","Fungederm","Gyne-lotrimin","Gyne-lotrimin 3","Gyne-lotrimin 3 combination pack","Gyne-lotrimin combination pack","Gynix","Masnoderm","Mycelex","Mycelex-7","Mycelex-7 combination pack","Mycelex-g","Mycil gold","Privacom","Trimysten","Trivagizole 3"],"synonyms":["BAY 5097","BAY-5097","Clotrimazole","GNF-PF-3499","Lotrimin","NSC-257473","SVT-15652","Svt-15652","Trivagizole"],"crossReferences":{"DailyMed":["clotrimazole"],"PubChem":["11110962","11110963","11532882","124879671","144203662","144210733","170464807","26747486","26747487","50106076","50106077","50106078","50106079","569393","85230973","90340692"],"Wikipedia":["Clotrimazole"],"drugbank":["DB00257"],"chEBI":["3764"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1975 and has 7 approved and 8 investigational indications."}
{"id":"CHEMBL106502","canonicalSmiles":"COc1ccc(Sc2nc(N)nc3c2ncn3CCOCP(=O)(OCC(F)(F)F)OCC(F)(F)F)cc1","inchiKey":"VDBGPMJFHCJMOL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALAMIFOVIR","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alamifovir","LY-582563","MCC-478"],"crossReferences":{"drugbank":["DB06368"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1088977","canonicalSmiles":"C[S+](CC[C@H](N)C(=O)[O-])C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O","inchiKey":"MEFKEPWMEQBLKI-AIRLBKTGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ADEMETIONINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gumbaral","Moodplus","Samyr 200"],"synonyms":["Ademetionine","Ademetionine disulfate tosilate","Ademetionine disulfate tosylate","Ademetionine disulphate tosylate","Ademetionine sulfate tosilate","Ademetionine tosilate sulfate","Ademetionine tosilate sulphate","Adenosylmethionine","Adomet","MSI-195","S-adenosylmethionine","S-amet","SAM-E","SAME","Transmetil","Zentonil"],"crossReferences":{"drugbank":["DB00118"],"chEBI":["67040"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1092","canonicalSmiles":"Cl.OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1","inchiKey":"QDWJJTJNXAKQKD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIHEXYPHENIDYL HYDROCHLORIDE","yearOfFirstApproval":1949,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1490","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Agitane","Artane","Bentex","Broflex","Tremin","Trihexyphenidyl hydrochloride"],"synonyms":["Aparkane","Benzhexol","Benzhexol hydrochloride","Cyclodol","Cyclodolum","NSC-757357","Parcopane","Romparkin","Sedrina","Trihexyphenidyl HCl","Trihexyphenidyl hcl","Trihexyphenidyl hydrochloride","Trihexyphenidyli hydrochloridum","Triphedinon"],"crossReferences":{"DailyMed":["trihexyphenidyl%20hydrochloride"],"PubChem":["144204826","170464756","26747667","26747668","50107036","50107037","50107038","56422445","855814"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1949."}
{"id":"CHEMBL112570","canonicalSmiles":"CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"HVYWMOMLDIMFJA-DPAQBDIFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHOLESTEROL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cholest-5-en-3-ol (3.beta.)-","Cholesterin","Cholesterinum","Cholesterol","Cholestrin","Dythol","Lidinit","Lidinite","NSC-8798","Provitamin-d"],"crossReferences":{"PubChem":["26754461","29215267"],"Wikipedia":["Cholesterol"],"drugbank":["DB04540"],"chEBI":["16113"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL112834","canonicalSmiles":"CCCCn1c(Cc2ccc(OC)cc2)nc2c(N)ncnc21","inchiKey":"NVYATAJRTRFKSW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL112834","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03899"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1185","canonicalSmiles":"CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12","inchiKey":"ULSDMUVEXKOYBU-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZOLMITRIPTAN","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zolmitriptan","Zomig","Zomig-zmt"],"synonyms":["311-C-90","311C90","Cvt-427","NSC-760383","Zolmitriptan"],"crossReferences":{"DailyMed":["zolmitriptan"],"PubChem":["144205008","170464875"],"Wikipedia":["Zolmitriptan"],"drugbank":["DB00315"],"chEBI":["10124"]},"linkedTargets":{"rows":["ENSG00000135312","ENSG00000179546"],"count":2},"linkedDiseases":{"rows":["MONDO_0005277","EFO_0010445","EFO_0003843"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1997 and is indicated for migraine disorder."}
{"id":"CHEMBL1200333","drugType":"Small molecule","blackBoxWarning":false,"name":"TECHNETIUM TC 99M PYROPHOSPHATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL2110559","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cis-pyro","Phosphotec","Pyrophosphate kit","Technescan pyp kit"],"synonyms":["Technetium (99Mtc) Pyrophosphate","Technetium (99mtc) pyrophosphate","Technetium tc 99m pyrophosphate","Technetium tc-99m diphosphate","Technetium tc-99m pyrophosphate","Technetium tc-99m pyrophosphate kit"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1200384","canonicalSmiles":"CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C","inchiKey":"CIWBQSYVNNPZIQ-XYWKZLDCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETAMETHASONE DIPROPIONATE","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alphatrex","Betamethasone dipropionate","Diprolene","Diprolene af","Diprosone","Sernivo"],"synonyms":["Betamethasone (as dipropionate)","Betamethasone 17,21-dipropionate","Betamethasone dipropionate","Diprospan","Maxivate","NSC-758415","Rinderon dp","SCH 11460","SCH-11460"],"crossReferences":{"DailyMed":["betamethasone%20dipropionate"],"PubChem":["144206894","29215385"],"Wikipedia":["Betamethasone_dipropionate"],"chEBI":["31276"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_1001494","EFO_0007486","HP_0012532","EFO_0000701","EFO_0000274","HP_0001742","HP_0004798","EFO_1001097","HP_0006536","EFO_0000544","EFO_0000676","EFO_0004143","EFO_0009552","EFO_0008517","MONDO_0005178","EFO_0005752"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1975 and has 8 approved and 3 investigational indications."}
{"id":"CHEMBL1200667","canonicalSmiles":"CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"PYTMYKVIJXPNBD-BTKVJIOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENCLOMIPHENE CITRATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL954","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Androxal"],"synonyms":["(e)-clomiphene citrate","Clomiphene b citrate","Enclomid","Enclomiphene citrate","Trans-clomiphene citrate"],"crossReferences":{"PubChem":["11532948"],"Wikipedia":["Clomifene"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1201020","canonicalSmiles":"CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C.O=P(O)(O)O","inchiKey":"CGDDQFMPGMYYQP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DISOPYRAMIDE PHOSPHATE","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL517","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dirythmin","Dirythmin-sa","Disopyramide phosphate","Isomide cr","Norpace","Norpace cr","Rythmodan ret"],"synonyms":["Dirythmin sa","Diso-duriles","Disopyramide phosphate","NSC-756744","Rythmodan","SC-13957","SC-7031 PHOSPHATE"],"crossReferences":{"DailyMed":["disopyramide%20phosphate"],"PubChem":["50106185","855629"],"chEBI":["4658"]},"linkedTargets":{"rows":["ENSG00000185313","ENSG00000196876","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000007314","ENSG00000136531","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["EFO_0000275","EFO_0004269","EFO_0003144","HP_0004308"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1977 and is indicated for ventricular arrhythmia and cardiac arrhythmia and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201196","canonicalSmiles":"Clc1ccc(C(Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1","inchiKey":"JLGKQTAYUIMGRK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SERTACONAZOLE","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Demofix","Ertaczo","FI-7045","Sertaconazole"],"crossReferences":{"DailyMed":["sertaconazole%20nitrate"],"Wikipedia":["Sertaconazole"],"drugbank":["DB01153"],"chEBI":["83682"]},"childChemblIds":["CHEMBL1200725"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and is indicated for tinea pedis and has 2 investigational indications."}
{"id":"CHEMBL1201273","canonicalSmiles":"CC(Cc1ccc2c(c1)OCO2)NCC(O)c1ccc(O)c(O)c1","inchiKey":"LUMAEVHDZXIGEP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROTOKYLOL","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Asmeti","Caytine","Palisan","Protokylol","Ventaire"],"crossReferences":{"Wikipedia":["Protokylol"],"drugbank":["DB06814"]},"childChemblIds":["CHEMBL1200893"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201274","canonicalSmiles":"CC(C)NC[C@H](O)COc1ccc(CCOCC2CC2)cc1","inchiKey":"NWIUTZDMDHAVTP-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOBETAXOLOL","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Betaxolol, (s)-","Levobetaxolol"],"crossReferences":{"Wikipedia":["Levobetaxolol"],"drugbank":["DB09351"],"chEBI":["59254"]},"childChemblIds":["CHEMBL1200837"],"linkedTargets":{"rows":["ENSG00000043591"],"count":1},"linkedDiseases":{"rows":["EFO_1001069","EFO_0000516"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and has 2 investigational indications."}
{"id":"CHEMBL1201303","canonicalSmiles":"Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1","inchiKey":"QMHSXPLYMTVAMK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRVINIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Pyrvinium","Pyrvinium (cation)","Pyrvinium cation","Pyrvinium hydroxide","Pyrvinium ion","Pyrvinum (base)"],"crossReferences":{"Wikipedia":["Pyrvinium"],"drugbank":["DB06816"],"chEBI":["8687"]},"childChemblIds":["CHEMBL1908377","CHEMBL4303307","CHEMBL2105340","CHEMBL4645638","CHEMBL1572280"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for helminthiasis."}
{"id":"CHEMBL1201459","drugType":"Enzyme","blackBoxWarning":false,"name":"DESOXYRIBONUCLEASE","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Deanase"],"synonyms":["Deoxyribonuclease","Deoxyribonuclease i","Deoxyribonuclease i bovine","Deoxyribonuclease, bovine","Desoxyribonuclease","Dinase","Dornavac","Pancreatic dornase"],"description":"Enzyme drug with a maximum clinical trial phase of IV that was first approved in 1964."}
{"id":"CHEMBL1201569","drugType":"Unknown","blackBoxWarning":true,"name":"BOTULINUM TOXIN TYPE B","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Myobloc","Neurobloc"],"synonyms":["AN-0772","Botulin b","Botulinum toxin type b"],"crossReferences":{"DailyMed":["botulinum%20toxin%20type%20b"]},"linkedTargets":{"rows":["ENSG00000220205"],"count":1},"linkedDiseases":{"rows":["HP_0200042","EFO_0000275","HP_0000726","HP_0009762","HP_0000473","EFO_1000632","HP_0000975","HP_0003419","EFO_0004143","HP_0002307"],"count":10},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and has 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201731","canonicalSmiles":"Cl.OC(CNCC(O)C1CCc2cc(F)ccc2O1)C1CCc2cc(F)ccc2O1","inchiKey":"JWEXHQAEWHKGCW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEBIVOLOL HYDROCHLORIDE","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL434394","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bystolic","Nebivolol hydrochloride"],"synonyms":["Nebivolol hcl","Nebivolol hydrochloride","R-067555","R067555","RO67555"],"crossReferences":{"DailyMed":["nebivolol%20hydrochloride"]},"linkedTargets":{"rows":["ENSG00000169252","ENSG00000043591"],"count":2},"linkedDiseases":{"rows":["EFO_0000712","EFO_0000537"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and is indicated for hypertension and stroke."}
{"id":"CHEMBL1230270","canonicalSmiles":"CN(C)CCCCSC(=N)N","inchiKey":"UFYJLJINUGVUHO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230270","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111760","11113540","124881365","124881367","26751749","50104444"],"drugbank":["DB07106"]},"childChemblIds":["CHEMBL1398213"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230763","canonicalSmiles":"COC(=O)c1ccc(NC(=O)NC[C@H]2CC[C@@H](C(=O)N3CCC[C@H]3CN)N2)cc1","inchiKey":"USDCNOQKDUFKRD-IKGGRYGDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230763","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07328"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231533","canonicalSmiles":"O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1","inchiKey":"SRLVNYDXMUGOFI-YWEYNIOJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231533","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["90341251"],"drugbank":["DB07503"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231847","canonicalSmiles":"Cc1ccc(S(=O)(=O)NCCCOC(=O)Nc2ccncc2)cc1","inchiKey":"ITYCDQJBLCTIID-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231847","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["4241792"],"drugbank":["DB07572"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236184","canonicalSmiles":"Cc1ncnc2c1ncn2[C@@H]1O[C@H]([C@H](C)O)[C@@H](O)[C@H]1O","inchiKey":"XJZDIUOABWMPLZ-DSBXBFMBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236184","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02934"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1330","canonicalSmiles":"CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)C=C[C@H]3[C@H]1C5","inchiKey":"GNJCUHZOSOYIEC-GAROZEBRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MORPHINE GLUCURONIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Morphine 6-.beta.-d-glucuronide","Morphine 6-Glucuronide(Minor)","Morphine 6-glucuronide","Morphine glucuronide","Morphine glucuronide, (-)-","Morphine-6-glucuronide"],"crossReferences":{"Wikipedia":["Morphine-6-glucuronide"],"drugbank":["DB06409"],"chEBI":["80581"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1433361","canonicalSmiles":"CCCCCCCCOc1ccccc1C(=O)Nc1ccc(C(=O)OCC[N+](C)(CC)CC)cc1","inchiKey":"NQHNLNLJPDMBFN-UHFFFAOYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"OTILONIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Octylonium","Otilonium cation","Otilonium ion"],"crossReferences":{"PubChem":["26756890"],"drugbank":["DB13500"]},"childChemblIds":["CHEMBL2103773"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL148","canonicalSmiles":"C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(SCCNC=N)C[C@H]12","inchiKey":"ZSKVGTPCRGIANV-ZXFLCMHBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMIPENEM","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Imipenem","MK-0787"],"crossReferences":{"DailyMed":["imipenem"],"PubChem":["144204240","170464934","90341794"],"drugbank":["DB01598"],"chEBI":["471744"]},"childChemblIds":["CHEMBL43708"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 5 approved and 7 investigational indications."}
{"id":"CHEMBL1524273","canonicalSmiles":"O=C(O)c1ccccc1C(=O)Nc1ccc(S(=O)(=O)Nc2nccs2)cc1","inchiKey":"PBMSWVPMRUJMPE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHTHALYLSULFATHIAZOLE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Thalazole"],"synonyms":["NSC-66454","NSC-683525","Phthalylsulfathiazole","Phthalylsulfhathiazole","Phthalylsulphathiazole","Sulfaphtalylthiazol","Sulfathalidine"],"crossReferences":{"PubChem":["11112227","144203931","170466178","56463086"],"drugbank":["DB13248"],"chEBI":["9336"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1537","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2[C@H]1C(=O)O","inchiKey":"JTWOMNBEOCYFNV-NFFDBFGFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZLOCILLIN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Azlin"],"synonyms":["Azlocillin","J01CA09","NSC-758227"],"crossReferences":{"Wikipedia":["Azlocillin"],"drugbank":["DB01061"],"chEBI":["2956"]},"childChemblIds":["CHEMBL1201041"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for bacterial disease."}
{"id":"CHEMBL155103","canonicalSmiles":"CCOC(=O)c1cc2ccc(O)cc2oc1=O","inchiKey":"IETDBZQIWIJQJG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL155103","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02728"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL157101","canonicalSmiles":"CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1","inchiKey":"XMAYWYJOQHXEEK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"KETOCONAZOLE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Daktarin gold","Daktarin intensiv","Dandrazol","Dandrid","Extina","Ketoconazole","Ketopine","Ketosidin","Ketozole","Nizoral","Nizoral a-d","Nizoral anti-dandruff","Nizorelle","Panfungol","Xolegel"],"synonyms":["J02AB02","Ketoconazole","Ketoconazolum","NSC-317629","R 41,400","R-41400"],"crossReferences":{"DailyMed":["ketoconazole"],"PubChem":["456469"],"drugbank":["DB01026"],"chEBI":["48339"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 5 approved and 34 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1628161","canonicalSmiles":"C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3[C@@H](OC)C[C@@]21C","inchiKey":"MTMZZIPTQITGCY-OLGWUGKESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOXESTROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Metoxiestrol","Moxestrol","R 2858","R-2858"],"crossReferences":{"drugbank":["DB13418"],"chEBI":["34857"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1697825","canonicalSmiles":"CCCCN(CCCC)CCNc1nc(-c2ccccc2)no1","inchiKey":"VYWQZAARVNRSTR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTALAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Butalamine","LA 1221 [AS HYDROCHLORIDE]"],"crossReferences":{"drugbank":["DB13681"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1707","canonicalSmiles":"CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1.Cl","inchiKey":"PGYPOBZJRVSMDS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LOPERAMIDE HYDROCHLORIDE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL841","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arret","Diah-limit","Diaquitte","Diareze","Diarrhoea relief","Diasorb","Diocalm","Diocaps","Dioraleze","Entrocalm","Gppe pack","Imodium","Imodium Advanced","Imodium a-d","Imodium a-d ez chews","Imodium classic","Imodium ibs relief","Imodium instant melts","Imodium instants","Imodium liquicaps","Lodiar","Loperagen","Loperamide hydrochloride","Norimode","Normaloe"],"synonyms":["Loperamide hcl","Loperamide hydrochloride","Loperamidi hydrochloridum","NSC-696356","R 18,553","R-18553"],"crossReferences":{"DailyMed":["loperamide%20hydrochloride"],"PubChem":["11533030","26747556","26747557","50106525","50125622","56422888"],"chEBI":["6533"]},"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["HP_0002014","EFO_0009523"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1976 and is indicated for diarrhea. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1732","canonicalSmiles":"CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21","inchiKey":"LUZRJRNZXALNLM-JGRZULCMSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DIHYDROERGOTAMINE","yearOfFirstApproval":1946,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["9,10-dihydroergotamine","Dihydroergotamine","MAP-0004","MAP0004","Neomigran"],"crossReferences":{"DailyMed":["dihydroergotamine%20mesylate"],"PubChem":["104171355","124883195","144204372","170465012","26751735","50104427","90341683"],"Wikipedia":["Dihydroergotamine"],"drugbank":["DB00320"],"chEBI":["4562"]},"childChemblIds":["CHEMBL1200517"],"linkedTargets":{"rows":["ENSG00000179546"],"count":1},"linkedDiseases":{"rows":["MONDO_0100431","MONDO_0005277","MONDO_0005475"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1946 and is indicated for migraine disorder and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1738758","canonicalSmiles":"CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1","inchiKey":"QHLVBNKYJGBCQJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ONVANSERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NMS-1286937","NMS-P937","Nms-1286937","Onvansertib","PCM-075"],"crossReferences":{"drugbank":["DB15110"]},"childChemblIds":["CHEMBL4298158","CHEMBL1774489"],"linkedTargets":{"rows":["ENSG00000166851"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1001480","EFO_0002517","EFO_0000222","MONDO_0008315"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1743005","drugType":"Antibody","blackBoxWarning":false,"name":"DACETUZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dacetuzumab","HU-S2C6","HUS2C6","SGN-40"],"linkedTargets":{"rows":["ENSG00000101017"],"count":1},"linkedDiseases":{"rows":["EFO_0000095","EFO_0000403","EFO_0001378","EFO_0005952"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL175970","canonicalSmiles":"N[C@@H](CSCP(=O)(O)O)C(=O)O","inchiKey":"IIALWEPLPCANHU-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL175970","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02461"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1771","canonicalSmiles":"COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1","inchiKey":"GKTWGGQPFAXNFI-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CLOPIDOGREL","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Grepid","Iscover","Plavix"],"synonyms":["Clopidogrel","Clopidogrel 1a-pharma","Clopidogrel acino","Clopidogrel apotex","Clopidogrel benzenesulfonate","Clopidogrel besilate","Clopidogrel besylate","Clopidogrel hexal","Clopidogrel sandoz","Clopidogrel-ratiopharm","NSC-758613","R 130964","R-130964","SR 25990","SR-25990","Zyllt"],"crossReferences":{"DailyMed":["clopidogrel%20bisulfate"],"PubChem":["49666065","49666423"],"Wikipedia":["Clopidogrel"],"drugbank":["DB00758"],"chEBI":["37941"]},"childChemblIds":["CHEMBL1083385"],"linkedTargets":{"rows":["ENSG00000169313"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","EFO_0001361","EFO_0003777","HP_0002239","EFO_0000275","MONDO_0002009","EFO_0000266","EFO_0003913","EFO_0003914","EFO_0008585","EFO_0003870","EFO_0002690","HP_0004420","EFO_0003884","EFO_0007541","EFO_1000059","EFO_0000400","EFO_0009686","HP_0001685","EFO_0000180","EFO_0004286","EFO_0004607","EFO_0002429","MP_0001914","MONDO_0100096","MONDO_0000831","EFO_0009659","EFO_0007328","MONDO_0004979","HP_0030680","EFO_0005672","EFO_1000860","MONDO_0002679","EFO_1000883","EFO_0003876","EFO_0002950","MONDO_0005277","MONDO_0001056","EFO_1000044","EFO_1001216","EFO_0003144","EFO_0000712","EFO_0020925","HP_0004419","EFO_0000717","EFO_0006859","HP_0002140","EFO_0000545","EFO_0003875","EFO_0001645","EFO_0000556","EFO_0009315","EFO_0000319","EFO_0004277","GO_0070527","EFO_0002615","EFO_0000537","EFO_0003106","EFO_0000195","EFO_1000881","EFO_0003764","EFO_1000985","EFO_0000764","EFO_0009086","EFO_0008583","EFO_0000612","EFO_1001207","EFO_0010820","MONDO_0005148","EFO_0004265","EFO_0004264"],"count":71},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and has 8 approved and 46 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL177820","canonicalSmiles":"Brc1c(Br)c(Br)c2[nH]nnc2c1Br","inchiKey":"OMZYUVOATZSGJY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRABROMOBENZOTRIAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4,5,6,7-Tetrabromobenzotriazole"],"crossReferences":{"PubChem":["26753256","26753257","90341691"],"drugbank":["DB04462"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL189959","canonicalSmiles":"CCCCCCCC/C=C/CCCCCCCC(=O)OCC(O)COP(=O)(O)O","inchiKey":"WRGQSWVCFNIUNZ-MDZDMXLPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLEOYL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL191896"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL190467","canonicalSmiles":"O=C1C(c2ccc(O)cc2)=C(Br)c2ccc(O)cc21","inchiKey":"DHPCBFMFERFZLR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL190467","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07230"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1950553","canonicalSmiles":"Nc1nc(OCCc2ccc(Cl)cc2)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"WUCQGGOGHZRELS-LSCFUAHRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SONEDENOSON","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MRE-0094","MRE0094","Mre0094","Sonedenoson"],"crossReferences":{"drugbank":["DB12443"]},"linkedTargets":{"rows":["ENSG00000128271"],"count":1},"linkedDiseases":{"rows":["EFO_1001459"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2028987","canonicalSmiles":"CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(NC(=O)[C@@H]2CC(=O)NC(=O)N2)cc1)C(=O)N[C@H](Cc1ccc(NC(N)=O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O.CC(=O)O","inchiKey":"AUTFSFUMNFDPLH-KYMMNHPFSA-N","drugType":"Protein","blackBoxWarning":false,"name":"DEGARELIX ACETATE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL415606","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Firmagon"],"synonyms":["Degarelix (as acetate)","Degarelix acetate","Degarelix acetate hydrate","FE-200486","FE200486","FE200486 (FREE BASE)"],"crossReferences":{"DailyMed":["degarelix%20acetate"]},"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0000673","MONDO_0008315","EFO_0001663"],"count":3},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and has 3 approved indications."}
{"id":"CHEMBL206834","canonicalSmiles":"Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1","inchiKey":"ZGBAJMQHJDFTQJ-DEOSSOPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BAFETINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bafetinib","CNS-9","INNO-406","NS-187"],"crossReferences":{"drugbank":["DB11851"]},"linkedTargets":{"rows":["ENSG00000097007","ENSG00000254087"],"count":2},"linkedDiseases":{"rows":["EFO_0000095","MONDO_0008315"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2103883","canonicalSmiles":"O=C(Nc1nc(-c2cc(Cl)cs2)c(N2CCN(C3CCCCC3)CC2)s1)c1cnc(N2CCC(C(=O)O)CC2)c(Cl)c1","inchiKey":"OFZJKCQENFPZBH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AVATROMBOPAG","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Akr-501","Avatrombopag","E-5501","E5501","YM-301477","YM-477"],"crossReferences":{"DailyMed":["avatrombopag%20maleate"],"drugbank":["DB11995"]},"childChemblIds":["CHEMBL2105758"],"linkedTargets":{"rows":["ENSG00000117400"],"count":1},"linkedDiseases":{"rows":["MP_0001914","EFO_0007160","EFO_0001421","HP_0001915","MONDO_0002245","HP_0001873"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 3 approved and 5 investigational indications."}
{"id":"CHEMBL2104534","canonicalSmiles":"NC(=O)OCC(O)c1ccccc1","inchiKey":"OCSOHUROTFFTFO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"STYRAMATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Linaxar","Myospaz","NSC-115889","Sinaxar","Styramate"],"crossReferences":{"drugbank":["DB13357"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104585","canonicalSmiles":"CC(C)c1cc2c(cc1S(=O)(=O)O)[C@@]1(C)CCC[C@@](C)(C(=O)O)[C@@H]1CC2","inchiKey":"IWCWQNVIUXZOMJ-MISYRCLQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ECABET","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ecabet","Ecabet sodium"],"crossReferences":{"PubChem":["144206316"],"drugbank":["DB05265"]},"childChemblIds":["CHEMBL3343738","CHEMBL3186947","CHEMBL4303208"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2104769","canonicalSmiles":"CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1O[11CH3]","inchiKey":"WAOQONBSWFLFPE-TXWZUYSVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RACLOPRIDE C 11","maximumClinicalTrialPhase":1,"parentId":"CHEMBL8809","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(11c)-raclopride","Raclopride c 11","Raclopride c-11"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2104985","canonicalSmiles":"N.Nc1nc(N)c2nc(CNc3ccc(C(=O)N[C@@H](CCCNC(=O)c4ccccc4C(=O)O)C(=O)O)cc3)cnc2n1","inchiKey":"CURXCENNYPPKOS-FYZYNONXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALOTREXIN AMMONIUM","maximumClinicalTrialPhase":1,"parentId":"CHEMBL590985","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-712783","PT-523","PT523","Talotrexin ammonium"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2106710","canonicalSmiles":"Cl.Oc1ccc2c(c1)C(Cc1c[nH]cn1)CC2","inchiKey":"OYKZVKWXOWICFI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FADOLMIDINE HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2104262","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fadolmidine hcl","Fadolmidine hydrochloride","MPV-2426","Radolmidine hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2107859","drugType":"Unknown","blackBoxWarning":false,"name":"ROZROLIMUPAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rozrolimupab","SYM-001","SYM001"],"linkedTargets":{"rows":["ENSG00000187010"],"count":1},"linkedDiseases":{"rows":["EFO_0007160"],"count":1},"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2107885","drugType":"Enzyme","blackBoxWarning":false,"name":"RETEPLASE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rapilysin","Retavase"],"synonyms":["BM 06.022","BM-06.022","BM-06022","Ecokinase","Retavase","Reteplase","Reteplase, recombinant","Reteplase,recombinant","Retevase"],"crossReferences":{"DailyMed":["reteplase"],"DrugCentral":["5044"]},"linkedTargets":{"rows":["ENSG00000122194"],"count":1},"linkedDiseases":{"rows":["EFO_0008585","EFO_0003144","EFO_0000712","EFO_0008583","EFO_0000612","HP_0004419"],"count":6},"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 3 approved and 2 investigational indications."}
{"id":"CHEMBL2108253","drugType":"Antibody","blackBoxWarning":false,"name":"ARCITUMOMAB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Cea-scan"],"synonyms":["Arcitumomab","IMMU-4"],"crossReferences":{"DrugCentral":["5127"]},"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108290","drugType":"Protein","blackBoxWarning":false,"name":"EPOETIN THETA","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eporatio"],"synonyms":["Epoetin theta"],"crossReferences":{"DrugCentral":["5007"]},"description":"Protein drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2108594","drugType":"Protein","blackBoxWarning":false,"name":"EPTOTERMIN ALFA","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bmp-7","Bone morphogenetic protein 7","Eptotermin alfa","Hbmp7","Opgenra","Osigraft","Osteogenic protein 1","Rh-polypeptide-52"],"crossReferences":{"DrugCentral":["5175"]},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) and is indicated for bone disease and has 1 investigational indication."}
{"id":"CHEMBL2108708","drugType":"Antibody","blackBoxWarning":false,"name":"YTTRIUM Y 90 CLIVATUZUMAB TETRAXETAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Hpam4-cide"],"synonyms":["90HY-PAM4","90Y-HPAM4","90Y-HPAMA4","HPAM-4-DOTA","HPAM-DOTA HY-PAM4","HPAM4-DOTA","IMMU-107","S9S0HY-PAM4","Yttrium (90y) clivatuzumab tetraxetan","Yttrium y 90 clivatuzumab tetraxetan"],"linkedTargets":{"rows":["ENSG00000215182"],"count":1},"linkedDiseases":{"rows":["EFO_0002618"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108956","drugType":"Unknown","blackBoxWarning":false,"name":"HYPROMELLOSE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Artelac","Artelac sdu","Brolene","Dacriosol","Genteal","Goniosol","Isopto tears","Methocel e, f, j, k","Moisture-eyes","Tearisol","Tears naturale","Ultra tears"],"synonyms":["Gonisol","Hydroxypropyl methylcellulose","Hydroxypropyl methylcelluloses","Hydroxypropylmethylcellulose","Hypromellose","Hypromellose 4000","Hypromellose, unspecified","Hypromelloses","Methylcellulose, propylene glycol ether of","Propylene glycol ether of methylcellulose"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2109516","drugType":"Antibody","blackBoxWarning":false,"name":"SS1(DSFV)-PE38","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SS1(DSFV)-PE38","Ss1(dsfv)-pe38"],"linkedTargets":{"rows":["ENSG00000102854"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0002618","MONDO_0002158","EFO_0006859","EFO_0000588","MONDO_0002974","MONDO_0008170","MONDO_0008903","MONDO_0002087"],"count":9},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL2110773","canonicalSmiles":"C[N+]1(CC2CC2)[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@@H]21","inchiKey":"QVVOZYKELHAIPX-WVHCHWADSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CIMETROPIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cimetropium cation","Cimetropium ion"],"crossReferences":{"drugbank":["DB09271"]},"childChemblIds":["CHEMBL2105977"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2110774","canonicalSmiles":"CN(C)CCOC(C)(c1ccccc1)c1ccc(Cl)cc1","inchiKey":"KKHPNPMTPORSQE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORPHENOXAMINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Chlorphenoxamine"],"crossReferences":{"drugbank":["DB09007"]},"childChemblIds":["CHEMBL2105980"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["HP_0000989","MONDO_0005271"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for pruritus and allergic disease."}
{"id":"CHEMBL2110796","canonicalSmiles":"C[N+](C)(C)CCOC(Cc1ccccc1)c1ccccc1","inchiKey":"LBRNZQRZDLLIHL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIBENZONIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bibenzonium cation","Bibenzonium ion"],"crossReferences":{"drugbank":["DB13630"]},"childChemblIds":["CHEMBL2106083"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL21932","canonicalSmiles":"COc1ccc(C(=O)O)cc1","inchiKey":"ZEYHEAKUIGZSGI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"p-ANISIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Methoxy-Benzoic Acid","4-Methoxybenzoate","4-Methoxybenzoic Acid","P-Methoxybenzoic Acid"],"crossReferences":{"Wikipedia":["P-Anisic_acid"],"drugbank":["DB02795"],"chEBI":["40813"]},"childChemblIds":["CHEMBL1762657"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL220087","canonicalSmiles":"Oc1c(Br)cc(Br)cc1Br","inchiKey":"BSWWXRFVMJHFBN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2,4,6-Tribromophenol","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2,4,6-Tribromophenol"],"crossReferences":{"PubChem":["144204649","144208471","144213289","170466870","17389588","26752930","56463483"],"Wikipedia":["2,4,6-Tribromophenol"],"drugbank":["DB02417"],"chEBI":["47696"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2325741","canonicalSmiles":"NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1","inchiKey":"JDUBGYFRJFOXQC-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAPIVASERTIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZC5363","AZD-5363","AZD5363","Azd 5363","Azd-5363","Capivasertib"],"crossReferences":{"drugbank":["DB12218"]},"linkedTargets":{"rows":["ENSG00000105221","ENSG00000117020","ENSG00000142208"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","EFO_0005232","Orphanet_145","EFO_0003869","EFO_1001958","EFO_0000503","EFO_0001642","MONDO_0015686","MONDO_0008170","MONDO_0007254","EFO_0000228","EFO_0003060","MONDO_0008315","EFO_0000311","MONDO_0001056","EFO_0000096","MONDO_0002974","MONDO_0011962","EFO_1000251","EFO_0000673","EFO_0001378","Orphanet_2495","EFO_0000707"],"count":23},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 18 investigational indications."}
{"id":"CHEMBL23588","canonicalSmiles":"O=C(O)c1ccccc1Nc1cccc(C(F)(F)F)c1","inchiKey":"LPEPZBJOKDYZAD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUFENAMIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arlef","Meralen"],"synonyms":["CI 440","CI-440","CN-27,554","CN-27554","Flufenamate","Flufenamic acid","INF-1837","NSC-219007","NSC-82699"],"crossReferences":{"PubChem":["104171306","11112395","124882329","144204003","144212428","170465857","26747013","26751533","26751535","56422408","855855"],"Wikipedia":["Flufenamic_acid"],"drugbank":["DB02266"],"chEBI":["42638"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for rheumatic disease."}
{"id":"CHEMBL2364665","drugType":"Small molecule","blackBoxWarning":false,"name":"ASTODRIMER","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Vivagel"],"synonyms":["6436 (NIH Compound Number)","Astodrimer","BRI 7013","BRI-7013","BRI7013","SPL 7013","SPL-7013","SPL7013"],"crossReferences":{"DrugCentral":["5050"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL253825","canonicalSmiles":"CCOc1c(Cl)cc(N2CCCCC2)cc1NC(=O)c1cc(C)c(OCCN)c(C)c1","inchiKey":"CKBBGCJYKCLKHE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL253825","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07626"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL255863","canonicalSmiles":"Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1","inchiKey":"HHZIURLSWUIHRB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"NILOTINIB","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tasigna"],"synonyms":["AMN 107","AMN-107","AMN107","NSC-747599","Nilotinib"],"crossReferences":{"DailyMed":["nilotinib%20hydrochloride"],"PubChem":["124894351","124894352","99460838"],"Wikipedia":["Nilotinib"],"drugbank":["DB04868"],"chEBI":["52172"]},"childChemblIds":["CHEMBL1201740"],"linkedTargets":{"rows":["ENSG00000097007","ENSG00000186716"],"count":2},"linkedDiseases":{"rows":["EFO_0001361","EFO_0000693","EFO_0000756","MONDO_0007254","MONDO_0021063","MONDO_0003541","MONDO_0000437","EFO_0000565","Orphanet_178","EFO_1000218","EFO_0000339","MONDO_0005180","EFO_0000389","EFO_0000326","EFO_0000717","EFO_0002617","EFO_0000616","MONDO_0013730","EFO_0000220","Orphanet_44890","EFO_0000222","EFO_1001106","EFO_1001968","MONDO_0003865","EFO_0000311","MONDO_0002171","Orphanet_399","MONDO_0004975","MONDO_0021637","MONDO_0004643"],"count":30},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and has 3 approved and 24 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL271591","canonicalSmiles":"Nc1nc(OC[C@H]2CCC(=O)N2)c2nc[nH]c2n1","inchiKey":"UYPMMHCTXQIWDX-RXMQYKEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL271591","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02898"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL298470","canonicalSmiles":"COc1cc(C)c2c(Oc3cccc(C(F)(F)F)c3)c(OC)cc(NC(C)CCCN)c2n1","inchiKey":"LBHLFPGPEGDCJG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAFENOQUINE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["SB-252263-AAB","Tafenoquine","WR 238605"],"crossReferences":{"DailyMed":["tafenoquine%20succinate"],"Wikipedia":["Tafenoquine"],"drugbank":["DB06608"]},"childChemblIds":["CHEMBL2364635"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for malaria and plasmodium vivax malaria and has 3 investigational indications."}
{"id":"CHEMBL300461","canonicalSmiles":"CCCN(C)C(=O)[C@@H]1OC(C(=O)O)=C[C@H](NC(=N)N)[C@H]1NC(C)=O","inchiKey":"QPJWMZVTNXFTKV-JMJZKYOTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL300461","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03503"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3039537","drugType":"Enzyme","blackBoxWarning":false,"name":"SEBELIPASE ALFA","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kanuma"],"synonyms":["SBC-102","Sebelipase alfa"],"crossReferences":{"DailyMed":["sebelipase%20alfa"],"DrugCentral":["5028"]},"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for cholesteryl ester storage disease and lysosomal acid lipase deficiency and has 1 investigational indication."}
{"id":"CHEMBL317094","canonicalSmiles":"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1C(=O)N(C)C[C@H]1C(=O)O","inchiKey":"KLZWOWYOHUKJIG-BPUTZDHNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMIDAPRIL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tanatril"],"synonyms":["Hipertene","Imidapril","Imidapril hcl","Imidapril hydrochloride","Imidapril monohydrochloride","TA 6366","TA-6366"],"crossReferences":{"Wikipedia":["Imidapril"],"drugbank":["DB11783"]},"childChemblIds":["CHEMBL3183293"],"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["MONDO_0001134","EFO_0000319","EFO_1001496"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cardiovascular disease and has 2 investigational indications."}
{"id":"CHEMBL3183117","canonicalSmiles":"O=C(O)CNC(=O)CNC(=O)CNC(=O)CSC(=O)c1ccccc1","inchiKey":"VDPYMEBVIDZKMD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3183117","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206816"],"drugbank":["DB14082"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3183654","canonicalSmiles":"Cc1cc(O)c(Cl)cc1C","inchiKey":"PSOJLBXHRBFLLQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3183654","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144212242"],"drugbank":["DB15658"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3301668","canonicalSmiles":"CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O","inchiKey":"NSTRIRCPWQHTIA-DTRKZRJBSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CARBETOCIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Duratocin","Duratocin long acting","Pabal"],"synonyms":["Carbetocin","FE 992097","FE-992097","LV-101"],"crossReferences":{"drugbank":["DB01282"],"chEBI":["59204"]},"linkedTargets":{"rows":["ENSG00000180914"],"count":1},"linkedDiseases":{"rows":["MP_0001914","Orphanet_739","EFO_0009658","EFO_0009579","MONDO_0001641","EFO_0002950"],"count":6},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3301800","canonicalSmiles":"CC=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccc(O)cc3)[C@H]2SC1","inchiKey":"WDLWHQDACQUCJR-PBFPGSCMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFPROZIL","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cefzil"],"synonyms":["BMY-28100-03-800","Cefprozil"],"crossReferences":{"DailyMed":["cefprozil"],"drugbank":["DB01150"],"chEBI":["3506"]},"childChemblIds":["CHEMBL3184906"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 7 approved and 1 investigational indication."}
{"id":"CHEMBL338076","canonicalSmiles":"NC(=O)c1cn([C@@H](CO)CCn2ccc3ccc(NC(=O)CCc4ccccc4)cc32)cn1","inchiKey":"GUYYFMCFEPDDFL-OAQYLSRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL338076","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07783"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL343448","canonicalSmiles":"C/C=C1\\NC(=O)[C@H]2CSSCC/C=C/[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@H](C(C)C)NC1=O","inchiKey":"OHRURASPPZQGQM-GCCNXGTGSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ROMIDEPSIN","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chromadax","Istodax"],"synonyms":["Depsipeptide","FK-228","FK228","FR-901228","FR901228","NSC-630176","Romidepsin"],"crossReferences":{"DailyMed":["romidepsin"],"PubChem":["144206460"],"drugbank":["DB06176"],"chEBI":["61080"]},"linkedTargets":{"rows":["ENSG00000108840","ENSG00000094631","ENSG00000061273","ENSG00000147099","ENSG00000163517","ENSG00000068024","ENSG00000116478","ENSG00000100429","ENSG00000171720","ENSG00000048052","ENSG00000196591"],"count":11},"linkedDiseases":{"rows":["MONDO_0004192","EFO_0000756","EFO_0002913","EFO_1001465","EFO_0000255","EFO_1001469","EFO_0005952","EFO_1000984","MONDO_0020654","EFO_1001951","MONDO_0001187","EFO_0000565","MONDO_0015760","MONDO_0008903","EFO_0000501","EFO_0000641","EFO_0002499","EFO_0000183","EFO_1000785","MONDO_0000430","EFO_0000616","EFO_0002618","MONDO_0019465","EFO_0000503","EFO_0000478","MONDO_0008170","EFO_0000403","EFO_0000180","EFO_0002501","EFO_0000224","EFO_0003060","MONDO_0008315","EFO_0000311","EFO_0000211","EFO_0000304","EFO_0003032","EFO_0006861","EFO_0000095","EFO_0005537","EFO_0002517","EFO_0000764","EFO_0000702","EFO_0000574","EFO_1001051","MONDO_0018906","EFO_0001378","MONDO_0024880","EFO_0000569"],"count":48},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and has 6 approved and 36 investigational indications."}
{"id":"CHEMBL3545404","drugType":"Small molecule","blackBoxWarning":false,"name":"CCX354","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CCX354","CCX354-C","Ccx-354","Ccx354","GSK-2941266","GSK2941266"],"linkedTargets":{"rows":["ENSG00000163823"],"count":1},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL361812","canonicalSmiles":"O=C(O)CCn1c2c(c3ccccc31)C[C@H](NS(=O)(=O)c1ccc(F)cc1)CC2","inchiKey":"LDXDSHIEDAPSSA-OAHLLOKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RAMATROBAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY U 3405","BAY-U-3405","Baynas","EN 137774","EN-137774","Ramatroban"],"crossReferences":{"PubChem":["144206069","170465980"],"Wikipedia":["Ramatroban"],"drugbank":["DB13036"]},"linkedTargets":{"rows":["ENSG00000006638","ENSG00000183134"],"count":2},"linkedDiseases":{"rows":["MONDO_0004979"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL369251","canonicalSmiles":"CC(=N)N1CCC(Oc2ccc3c4ccccc4n(Cc4ccc5ccc(C(=N)N)cc5c4)c3c2)CC1","inchiKey":"DZLGSWPXZYDHBD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL369251","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02112"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707243","canonicalSmiles":"C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1.Cc1ccc(S(=O)(=O)[O-])cc1.O","inchiKey":"UOWOLENSDISMPG-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"GLYCOPYRRONIUM TOSYLATE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201335","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Qbrexza"],"synonyms":["DRM-04","DRM04","Glycopyrronium tosylate"],"crossReferences":{"DailyMed":["glycopyrronium%20tosylate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 6 approved indications."}
{"id":"CHEMBL3707297","drugType":"Antibody","blackBoxWarning":false,"name":"CG250 177LU","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CG250","Cg250 (177lu)","Cg250 177lu"],"linkedTargets":{"rows":["ENSG00000107159"],"count":1},"linkedDiseases":{"rows":["EFO_0000681"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3707354","drugType":"Small molecule","blackBoxWarning":false,"name":"ABT-560","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abt-560"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707399","drugType":"Small molecule","blackBoxWarning":false,"name":"CX1739","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cx1739"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL374936","canonicalSmiles":"C[C@H](c1nc(-c2ccc(S(C)(=O)=O)cc2)no1)[C@H](N)C(=O)N1CCCC1","inchiKey":"SQCDMTZMCHZYGO-FZMZJTMJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL374936","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07067"],"chEBI":["39955"]},"childChemblIds":["CHEMBL403415"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3763743","canonicalSmiles":"Oc1ccc(Oc2sc3cc(O)ccc3c2-c2ccc(F)cc2)cc1","inchiKey":"UDBMVVLTKJMPCJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TTC-352","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SHERPA TTC-352","TTC-352","Ttc-352"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3833368","canonicalSmiles":"CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)O)C(=O)C2.CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1","inchiKey":"INBJJAFXHQQSRW-STOWLHSFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RUCAPARIB CAMSYLATE","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1173055","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rubraca"],"synonyms":["C0-338","CO-338","PF-1367338-BW","Rucaparib camsylate"],"crossReferences":{"DailyMed":["rucaparib%20camsylate"]},"linkedTargets":{"rows":["ENSG00000143799","ENSG00000129484","ENSG00000041880"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","EFO_0001075","MONDO_0008170","EFO_0000673"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and is indicated for ovarian carcinoma and ovarian cancer and has 2 investigational indications."}
{"id":"CHEMBL387675","canonicalSmiles":"CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C","inchiKey":"DOAKLVKFURWEDJ-RWDRXURGSA-N","drugType":"Protein","blackBoxWarning":false,"name":"DAPTOMYCIN","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cubicin","Cubicin rf","Daptomycin"],"synonyms":["Cidecin","Dapcin","Daptomycin","LY 146032","LY-146032","LY-164032"],"crossReferences":{"DailyMed":["daptomycin"],"chEBI":["600103"]},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and has 4 approved and 13 investigational indications."}
{"id":"CHEMBL3989978","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"PREXIGEBERSEN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BP-100-1.01/L-Grb2","BP-1001","L-grb-2 antisense","Prexigebersen"],"linkedTargets":{"rows":["ENSG00000177885"],"count":1},"linkedDiseases":{"rows":["EFO_0000222"],"count":1},"description":"Oligonucleotide drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3990804","canonicalSmiles":"Cc1oc(-c2ccccc2)nc1CCOc1ccc(CC2SC(=O)NC2=O)c2sccc12","inchiKey":"HAAXAFNSRADSMK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EDAGLITAZONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BM-131258","Edaglitazone","R-483"],"crossReferences":{"drugbank":["DB06519"]},"childChemblIds":["CHEMBL3989761"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL417007","canonicalSmiles":"C[C@H](C[C@@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)CCC(=O)O)C(=O)O","inchiKey":"DOBNVUFHFMVMDB-BEFAXECRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LBQ-657","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LBQ657","Lbq-657","Sacubitrilat"],"crossReferences":{"drugbank":["DB14127"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297192","drugType":"Small molecule","blackBoxWarning":false,"name":"SIMETHICONE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gas-x","Mylanta gas relief","Mylicon infant's drops","Sentry simethicone","Sentry simethicone emulsion"],"synonyms":["ANTIFOAM A","ANTIFOAM AF","Simethicone"],"crossReferences":{"DailyMed":["simethicone"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 6 investigational indications."}
{"id":"CHEMBL4297235","drugType":"Unknown","blackBoxWarning":false,"name":"OMBIPEPIMUT-S","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DSP-7888","Ombipepimut-s"],"linkedTargets":{"rows":["ENSG00000184937"],"count":1},"linkedDiseases":{"rows":["EFO_1000026","EFO_0000198","EFO_0000222","EFO_0000519"],"count":4},"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297241","drugType":"Gene","blackBoxWarning":false,"name":"PEMLIMOGENE MEROLISBAC","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ADU-214","JNJ-64041757","Pemlimogene merolisbac"],"description":"Gene drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297290","canonicalSmiles":"C[C@@H]1CN(Cc2ncccn2)C[C@H]1c1cn2c(C3CCOCC3)ncc2c(=O)[nH]1","inchiKey":"GWGNPYYVGANHRJ-GDBMZVCRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOVINONTRINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["68722","AF-68722","AF68722","CK-1598","CK1598","IMR-687","Imr-687","Tovinontrine"],"linkedTargets":{"rows":["ENSG00000160191"],"count":1},"linkedDiseases":{"rows":["Orphanet_232","Orphanet_848"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297378","canonicalSmiles":"CC1=C[C@@H]2CN(C(=O)N2OS(=O)(=O)[O-])[C@@H]1C(N)=O.[Na+]","inchiKey":"WHHNOICWPZIYKI-IBTYICNHSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"DURLOBACTAM SODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL4298137","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Durlobactam sodium","ETX-2514","ETX-2514 SODIUM","ETX2514","ETX2514 sodium","Etx2514"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297598","canonicalSmiles":"C[C@@H](C(=O)Nc1ccc(Cl)cc1)C1CCC(c2ccnc3ccc(F)cc23)CC1","inchiKey":"KRTIYQIPSAGSBP-KLAILNCOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LINRODOSTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS 986205","BMS-986205","Bms-986205","F 001287","F-001287","Linrodostat","ONO 7701","ONO-7701"],"childChemblIds":["CHEMBL4298147"],"linkedTargets":{"rows":["ENSG00000131203"],"count":1},"linkedDiseases":{"rows":["MONDO_0001056","EFO_0006859","MONDO_0002898","EFO_0000756","EFO_0000182","EFO_0000199","EFO_0003060","EFO_0000519","EFO_0000311","MONDO_0001187"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL4297962","drugType":"Unknown","blackBoxWarning":false,"name":"GNKG-168","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CPG-685","GNKG168","Gnkg-168","Gnkg168"],"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4298056","drugType":"Unknown","blackBoxWarning":false,"name":"IMMUNOCYTOKINE NHS-IL12","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Immunocytokine nhs-il12","M-9241","M9241","Nhs-il12"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4298124","drugType":"Antibody","blackBoxWarning":false,"name":"DOSTARLIMAB","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Jemperli"],"synonyms":["Dostarlimab","Dostarlimab-gxly","GSK-4057190","GSK4057190","TSR-042","Tsr 042","Tsr-042","WBP-285"],"linkedTargets":{"rows":["ENSG00000188389"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1000412","Orphanet_145","EFO_0002618","EFO_0006859","EFO_0003893","EFO_0000756","MONDO_0008170","EFO_1000657","MONDO_0007254","EFO_0003060","MONDO_0002691","EFO_0001061","EFO_0000588","EFO_0003968","MONDO_0002974","EFO_0005537","EFO_0002517","MONDO_0011962","EFO_0000702","EFO_0001378","MONDO_0024880","EFO_0000691"],"count":23},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2021 and is indicated for endometrial cancer and neoplasm and has 18 investigational indications."}
{"id":"CHEMBL4298130","drugType":"Antibody","blackBoxWarning":false,"name":"PLAMOTAMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Plamotamab","XENP13676","XMAB-13676","XmAb13676","Xmab13676"],"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4303525","canonicalSmiles":"CC1(C)CC[C@]2(NC(=O)C(C)(F)F)CC[C@]3(C)[C@H](C(=O)C=C4[C@@]3(C)CC[C@H]3C(C)(C)C(=O)C(C#N)=C[C@]43C)[C@@H]2C1","inchiKey":"RJCWBNBKOKFWNY-IDPLTSGASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OMAVELOXOLONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Omaveloxolone","RTA 408","RTA-408"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL43280","canonicalSmiles":"CN","inchiKey":"BAVYZALUXZFZLV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methanaminium","Methylamine"],"crossReferences":{"Wikipedia":["Methylamine"],"drugbank":["DB01828"],"chEBI":["16830"]},"childChemblIds":["CHEMBL3560728"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL439009","canonicalSmiles":"O=c1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@H]2O)c(=O)[nH]1","inchiKey":"HSCJRCZFDFQWRP-ABVWGUQPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL439009","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03501"],"chEBI":["67119"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL449062","canonicalSmiles":"C=C(C)[C@H]1CC=C(C)CC1","inchiKey":"XMGQYMWWDOXHJM-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"D-LIMONENE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(d)-limonene","Cajeputene","Cinene","D-limonene","Dipenten","Dipentene","Dipentene no. 122","Eulimen","FEMA NO. 2633","Kautschin","Limonene","Limonene, d-","Limonene, dl-","NSC-21446","NSC-757069","NSC-844","Nesol","Orange x"],"crossReferences":{"PubChem":["144207598"],"Wikipedia":["Limonene"],"drugbank":["DB08921"],"chEBI":["15382"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594263","drugType":"Unknown","blackBoxWarning":false,"name":"TOCOPHEROL HYDROCHLORIDE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Tocopherol hydrochloride"],"description":"Unknown drug with a maximum clinical trial phase of IV that was first approved in 2004."}
{"id":"CHEMBL4594431","canonicalSmiles":"CNC(=O)c1cccc(-c2ccc3c(N4C5CCC4COC5)nc(N4CCOC[C@@H]4C)nc3n2)c1","inchiKey":"LVPBYQVQBZLDAU-DZIBYMRMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MTI-31","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LXI-15029","Lxi-15029","MTI-31","Mti-31","SCC-31"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594512","drugType":"Unknown","blackBoxWarning":false,"name":"WN-80E","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HBV-002 COMPONENT WN-80E","WN-80E","Wn-80e"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650290","drugType":"Antibody","blackBoxWarning":false,"name":"GC1118","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GC1118","Gc1118"],"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0000503","EFO_0000519"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL469448","canonicalSmiles":"OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O","inchiKey":"WQZGKKKJIJFFOK-QTVWNMPRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"D-MANNOSE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Carubinose","D-mannose","Mannose","NSC-26247","Seminose"],"crossReferences":{"PubChem":["29217866","56323500"],"Wikipedia":["Mannose"],"chEBI":["4208"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL473841","canonicalSmiles":"CN(CC(=O)NC(c1cccc([N+](=O)[O-])c1)c1cc(Cl)c2cccnc2c1O)c1ccccc1","inchiKey":"CBUQIOYQSSZVDA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AGG-523","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Agg-523","PF-05212371","PF-5212371","WAY-266523"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL479079","canonicalSmiles":"COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC","inchiKey":"SQQAPOSROFWHIB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GW612286X","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW612286X"],"crossReferences":{"PubChem":["124349985"],"drugbank":["DB08519"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4802155","canonicalSmiles":"Nc1nnc(CN[C@@H]2C[C@H]2c2ccc(OCc3ccccc3)cc2)o1","inchiKey":"XBBRLCXCBCZIOI-DLBZAZTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VAFIDEMSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ORY-2001","Vafidemstat"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4802214","canonicalSmiles":"COc1cccc2[nH]c(C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]3CCNC3=O)C(=O)COP(=O)(O)O)cc12","inchiKey":"FQKALOFOWPDTED-WBAXXEDZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUFOTRELVIR","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lufotrelvir","PF-07304814","Pf-07304814"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL486422","canonicalSmiles":"O=c1c(-c2ccc(O)cc2)coc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc12","inchiKey":"KYQZWONCHDNPDP-QNDFHXLGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DAIDZIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dadzin","Daidzin"],"crossReferences":{"PubChem":["17504729","26756915"],"Wikipedia":["Daidzin"],"drugbank":["DB02115"],"chEBI":["42202"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL497689","canonicalSmiles":"Nc1ccc(S(=O)(=O)NC(=O)NCCS)cc1","inchiKey":"LHVDNDIAMJOEKH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL497689","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08484"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL49943","canonicalSmiles":"c1ccc(C(CCN2CCCCC2)c2ccccc2)cc1","inchiKey":"JXJPYHDHJZJWRI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENPIPRANE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fenpiprane"],"crossReferences":{"drugbank":["DB13439"]},"childChemblIds":["CHEMBL2106726"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL507870","canonicalSmiles":"CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O","inchiKey":"ONUMZHGUFYIKPM-MXNFEBESSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TELAVANCIN","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Telavancin","Televancin"],"crossReferences":{"DailyMed":["telavancin%20hydrochloride"],"drugbank":["DB06402"],"chEBI":["71229"]},"childChemblIds":["CHEMBL3301680"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and has 3 approved and 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL511942","canonicalSmiles":"Cc1cccc(CNC(=O)c2cc(C(=O)NCc3cccc(C)c3)ncn2)c1","inchiKey":"GTBUZLPQANSGGE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL511942","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04759"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL517140","canonicalSmiles":"CNC(=O)c1ccc(Oc2ccc3c(c2)CCN(C2CCC2)CC3)nc1","inchiKey":"WROHEWWOCPRMIA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK189254","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK189254","Gsk189254"],"crossReferences":{"Wikipedia":["GSK-189,254"]},"childChemblIds":["CHEMBL2031739"],"linkedTargets":{"rows":["ENSG00000101180"],"count":1},"linkedDiseases":{"rows":["MONDO_0021107"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL54918","canonicalSmiles":"O=c1[nH]c(=O)n([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1F","inchiKey":"FHIDNBAQOFJWCA-UAKXSSHOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"5-Fluorouridine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5-Fluorouridine"],"crossReferences":{"PubChem":["124892084","26754269"],"drugbank":["DB01629"],"chEBI":["40154"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL54922","canonicalSmiles":"O=C(O)[C@@H]1CCCN1","inchiKey":"ONIBWKKTOPOVIA-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FEMA NO. 3319","L-2-pyrrolidinecarboxylic acid","L-Proline","NSC-46703","Proline","Pyrrolidine-2-Carboxylic Acid"],"crossReferences":{"PubChem":["4253464"],"drugbank":["DB00172"],"chEBI":["17203"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL582912","canonicalSmiles":"CC/C=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1csc(N)n1","inchiKey":"HJJRIJDTIPFROI-NVKITGPLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFCAPENE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cefcapene"],"crossReferences":{"drugbank":["DB13461"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL6318","canonicalSmiles":"CC/C(=C(\\c1ccc(I)cc1)c1ccc(OCCN2CCCC2)cc1)c1ccccc1","inchiKey":"JJKOTMDDZAJTGQ-DQSJHHFOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IDOXIFENE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CB 7432","CB-7432","Idoxifene","SB-223030"],"crossReferences":{"Wikipedia":["Idoxifene"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL63893","canonicalSmiles":"N[C@@H](CCC(=O)NO)C(=O)O","inchiKey":"YVGZXTQJQNXIAU-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLUTAMINE HYDROXAMATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Glutamine Hydroxamate"],"crossReferences":{"drugbank":["DB02446"],"chEBI":["75305"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL65230","canonicalSmiles":"C=CCN(C)Cc1ccc(-c2ccc(C(=O)c3ccc(Br)cc3)cc2)cc1","inchiKey":"YATCZCSDJCQNAL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL65230","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03234"]},"childChemblIds":["CHEMBL481608"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL656","canonicalSmiles":"COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314","inchiKey":"BRUQQQPBMZOVGD-XFKAJCMBSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"OXYCODONE","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":["Oxycontin","Proladone","Xtampza er"],"synonyms":["(-)-14-hydroxydihydrocodeinone","14-hydroxydihydrocodeinone","Dihydrone","IDS-NO-002","N02AA05","NSC-19043","Oxicone","Oxycodone","Oxycodone cii","Oxymorphone 3-methyl ether","PF-00345439","PTI-821","Pavinal","Pti 821","Remoxy","Xtampza"],"crossReferences":{"DailyMed":["oxycodone","oxycodone%20hydrochloride","oxycodone%20terephthalate"],"Wikipedia":["Oxycodone"],"drugbank":["DB00497"],"chEBI":["7852"]},"childChemblIds":["CHEMBL1200890","CHEMBL3989826"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0003943","MONDO_0001583","HP_0000989","EFO_0007486","EFO_1001919","HP_0002018","EFO_1001951","EFO_0003931","EFO_1000786","EFO_0003100","EFO_0003884","EFO_0004253","MONDO_0005180","EFO_0004616","EFO_1001331","HP_0003419","EFO_0001069","HP_0008419","EFO_1002012","EFO_0003877","EFO_0005762","HP_0012532","EFO_0004329","EFO_0007493","EFO_0010072","HP_0002571","HP_0003418","EFO_0010702","EFO_0003843","EFO_0000311","EFO_0003890","MONDO_0002491","EFO_0009842","HP_0030833","EFO_0004273","EFO_0004209","EFO_1000999","EFO_0005611","EFO_0004270","MONDO_0005178","EFO_0000668","HP_0000023","HP_0002019"],"count":43},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1950 and has 4 approved and 26 investigational indications. It was withdrawn in United States. This drug has a black box warning from the FDA."}
{"id":"CHEMBL65717","canonicalSmiles":"Cc1cc2c(OCC(O)CNC(C)C)cccc2[nH]1","inchiKey":"NXWGWUVGUSFQJC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPINDOLOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mepindolol"],"crossReferences":{"drugbank":["DB13530"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL704","canonicalSmiles":"Nc1ccc(O)c(C(=O)O)c1","inchiKey":"KBOPZPXVLCULAV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MESALAMINE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Apriso","Asacol","Asacol hd","Canasa","Coltec ec","Delzicol","Ipocol","Lialda","Mesalamine","Mesren mr","Mezavant xl","Octasa","Pentasa","Pentasa sr","Rowasa","Salofalk","Sfrowasa"],"synonyms":["Benzoic acid, 5-amino-2-hydroxy-","Fisalamine","Iialda","MAX-002","Mesalamine","Mesalazine","Mesalazine ","NSC-38877"],"crossReferences":{"DailyMed":["mesalamine"],"PubChem":["104171289","11112235","144203935","144208808","144213442","170464840","17389224","26752847","49681712"],"Wikipedia":["Mesalazine"],"drugbank":["DB00244"],"chEBI":["6775"]},"linkedTargets":{"rows":["ENSG00000132170","ENSG00000012779","ENSG00000073756","ENSG00000095303"],"count":4},"linkedDiseases":{"rows":["Orphanet_144","EFO_0000729","EFO_0000765","EFO_0008572","EFO_0000555","HP_0002253","EFO_0005406","EFO_1001294","EFO_0007168","EFO_0000384","EFO_1001293","HP_0004798","EFO_1001951","EFO_1001460","EFO_0009959","EFO_0000764","EFO_0003872","EFO_0005628"],"count":18},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and is indicated for ulcerative colitis and proctitis and has 14 investigational indications."}
{"id":"CHEMBL713","canonicalSmiles":"C=C1[C@@H](n2cnc3c(=O)[nH]c(N)nc32)C[C@H](O)[C@H]1CO","inchiKey":"QDGZDCVAUDNJFG-FXQIFTODSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ENTECAVIR","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Baraclude","Entecavir"],"synonyms":["Anhydrous entecavir","BMS-200475-01","Baraclude","Entecavir","Entecavir anhydrous","Entecavir hydrate","Entecavir monohydrate","SQ-34676","SQ34676"],"crossReferences":{"DailyMed":["entecavir"],"PubChem":["144205745"],"Wikipedia":["Entecavir"],"drugbank":["DB00442"],"chEBI":["473990"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and has 4 approved and 7 investigational indications. This drug has a black box warning from the FDA."}
